These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33686920)

  • 21. Remimazolam: a short-acting benzodiazepine for procedural sedation.
    Paton DM
    Drugs Today (Barc); 2021 May; 57(5):337-346. PubMed ID: 34061128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
    Hu Q; Liu X; Wen C; Li D; Lei X
    Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD
    J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam.
    Io T; Saunders R; Pesic M; Petersen KU; Stoehr T
    Eur J Pharmacol; 2021 Apr; 896():173886. PubMed ID: 33493482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review.
    Sneyd JR; Gambus PL; Rigby-Jones AE
    Br J Anaesth; 2021 Jul; 127(1):41-55. PubMed ID: 33965206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis.
    Barbosa EC; Espírito Santo PA; Baraldo S; Meine GC
    Br J Anaesth; 2024 Jun; 132(6):1219-1229. PubMed ID: 38443286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent.
    Kim SH; Fechner J
    Korean J Anesthesiol; 2022 Aug; 75(4):307-315. PubMed ID: 35585830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent.
    Kilpatrick GJ
    Front Pharmacol; 2021; 12():690875. PubMed ID: 34354587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Narrative Review of Remimazolam in Procedural Sedation.
    Chen GC; Lin SS; Lin PA; Tseng WC; Lu CH
    Asian J Anesthesiol; 2023 Jun; 61(2):39-45. PubMed ID: 37386924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laryngeal edema following remimazolam-induced anaphylaxis: a rare clinical manifestation.
    Hu X; Tang Y; Fang X
    BMC Anesthesiol; 2023 Mar; 23(1):99. PubMed ID: 36991317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remimazolam for Sedation During Upper Gastrointestinal Endoscopy in an Adolescent.
    Garrett A; Flowers J; Ng V; Tobias JD
    J Med Cases; 2022 Oct; 13(10):495-498. PubMed ID: 36407860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment.
    Stöhr T; Colin PJ; Ossig J; Pesic M; Borkett K; Winkle P; Struys MMRF; Schippers F
    Br J Anaesth; 2021 Sep; 127(3):415-423. PubMed ID: 34246461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy.
    Pastis NJ; Yarmus LB; Schippers F; Ostroff R; Chen A; Akulian J; Wahidi M; Shojaee S; Tanner NT; Callahan SP; Feldman G; Lorch DG; Ndukwu I; Pritchett MA; Silvestri GA;
    Chest; 2019 Jan; 155(1):137-146. PubMed ID: 30292760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of intranasal remimazolam-a randomized controlled clinical trial.
    Pesic M; Schippers F; Saunders R; Webster L; Donsbach M; Stoehr T
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1505-1516. PubMed ID: 32886178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of bringing a new sedative to market!
    Sear JW
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):423-430. PubMed ID: 29847365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New benzodiazepines for sedation.
    Cornett EM; Novitch MB; Brunk AJ; Davidson KS; Menard BL; Urman RD; Kaye AD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):149-164. PubMed ID: 30322456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of remimazolam tosilate combined with low-dose fentanyl for procedural sedation in obese patients undergoing gastroscopy: study protocol for a single-centre, double-blind, randomised controlled trial.
    Yan L; Wang X; Chen Z; Wu N; Li H; Yang B
    BMJ Open; 2023 Dec; 13(12):e079095. PubMed ID: 38154891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remimazolam: A Novel Option for Procedural Sedation in High Risk Patients.
    Pantos MM; Kennedy DR; Nemec EC
    J Pharm Pract; 2023 Feb; 36(1):149-154. PubMed ID: 34155946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled Remimazolam Potentiates Inhaled Remifentanil in Rodents.
    Bevans T; Deering-Rice C; Stockmann C; Rower J; Sakata D; Reilly C
    Anesth Analg; 2017 May; 124(5):1484-1490. PubMed ID: 28333705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.